MENU
CLOSE
Home
News
2019 Announcements
Page 2
2019 Announcements
Filters:
Category
Latest
2016 Announcements
2017 Announcements
2018 Announcements
2019 Announcements
2020 Announcements
2021 Announcements
2022 Announcements
2023 Announcements
2024 Announcements
2025 Announcements
Clinical
Corporate
Financial
News
Newsletter
Pages
Presentation
Recruitment
Regulatory
Stories
Appendix 4C
2019 Announcements
31.10.2019
TGA Priority Registration Pathway for SCENESSE
2019 Announcements
30.10.2019
Letter from the Remuneration Committee Chair
2019 Announcements
30.10.2019
CLINUVEL Chair to Retire Following FDA Approval
2019 Announcements
18.10.2019
Appendix 4G and Corporate Governance Statement
2019 Announcements
18.10.2019
Annual Report to shareholders
2019 Announcements
18.10.2019
Notice of Annual General Meeting/Proxy Form
2019 Announcements
18.10.2019
CLINUVEL Newsletter
2019 Announcements
17.10.2019
Chair Letter to Shareholders
2019 Announcements
15.10.2019
Audio Transcript Investor Teleconference
2019 Announcements
10.10.2019
FDA Grants Marketing Approval For SCENESSE
2019 Announcements
09.10.2019
Trading Halt
2019 Announcements
08.10.2019
CLINUVEL Renews Employment Agreement With CEO
2019 Announcements
07.10.2019
.
‹
1
2
3
4
…
6
›
About
About CLINUVEL
People
Corporate Governance
Photomedicine Foundation
Annual Reports
Pharmaceuticals
Pharmaceutical Development
The Science
Disease Entities
Products
PhotoCosmetics
About PhotoCosmetics
Polychromatic Photoprotection
DNA Repair
Melanogenesis
Investors
Investors Information
ASX Announcements
Analyst Coverage
Media Coverage
Company Snapshot
Financial Summary
Shareholder Information
Investor Enquiry
News
Contact
Store
Go To Top